2026-04-29 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY DATABASE_REFERENCES citation citation_author em_admin _citation.country _citation.journal_abbrev _citation.journal_id_CSD _citation.journal_id_ISSN _citation.journal_volume _citation.page_first _citation.page_last _citation.pdbx_database_id_DOI _citation.pdbx_database_id_PubMed _citation.title _citation.year _em_admin.last_update EXPERIMENTAL_SUMMARY citation citation_author em_admin _citation.country _citation.journal_abbrev _citation.journal_id_CSD _citation.journal_id_ISSN _citation.journal_volume _citation.page_first _citation.page_last _citation.pdbx_database_id_DOI _citation.pdbx_database_id_PubMed _citation.title _citation.year _em_admin.last_update RCSB RCSB 2025-03-20 2026-02-25 2026-02-25 2026-04-29 Not funded SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab Local Refinement Map (RBD + Fv) Ramamohan AR Johnson NV McLellan JS SARS-CoV-2, Omicron, RBD, Fab, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM complex Zost SJ Suryadevara N Williamson LE Scheaffer SM Binshtein E Buchman CD Johnson NV Catanzaro NJ Ravera S Chapman NS Myers L Ramamohan AR Handal LS Nguyen DC Trivette A Martinez JR Villalobos E Rutherford SA Eun-Hyung Lee F Schafer A Baric RS McLellan JS Diamond MS Carnahan RH Crowe Jr JE Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. Nat Microbiol UK 11 1113 1132 2026 41820555 doi:10.1038/s41564-026-02282-x 2058-5276 EMD-49799 consensus EM volume 9nvg FULLOVERLAP EMDB EMD-49799 consensus EM volume EMDB EMD-49835 associated EM volume
Structure of SARS-CoV-2 BA.1 spike RBD bound to COV2-3835 Fab
 SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab 0 1 2 3 SARS-CoV-2 BA.1 S6P (HexaPro) 1 1 Severe acute respiratory syndrome coronavirus 2 COV2-3835 Fab 1 2 3 Homo sapiens Spike glycoprotein Severe acute respiratory syndrome coronavirus 2 BA.1 0.142586156
Trimeric viral fusion protein ectodomain
1 Homo sapiens LEVO MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNP VLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANN CTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLA LHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPT ESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIR GDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGV AGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQ QFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVF QTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHGSASSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVT TEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFS QILPDPSKPSKRSPIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTIT SGWTFGAGPALQIPFPMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTPSALGKLQDVVNHNAQALNTLV KQLSSKFGAISSVLNDIFSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFC GKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVS GNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL GKYEQGSGYIPEAPRDGQAYVRKDGEWVLLSTFLGRSLEVLFQGPGHHHHHHHHSAWSHPQFEKGGGSGGGGSGGSAWSH PQFEK P0DTC2 COV2-3835 Fab Heavy Chain Homo sapiens 0.024467711
Human IgG Antibody
1 Homo sapiens LEVO QITLKESGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGQALECLSLIYWNDDKRYSPSLKTRLTVTKDTSKNQV VLRMTNMDPVDTATYYCAHIGTDLLTGFWTDAFEIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFP EPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC COV2-3835 Fab Light Chain Homo sapiens 0.023525228999999998
Human IgG Antibody
1 Homo sapiens LEVO DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKVPKLLIYAASSLQSGVPPRFSGSGSGTDFTLTISTLQP EDFATYYCQQSYGMLWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGEC singleParticle particle 0.65 8.0 ETHANE 100 295 FEI VITROBOT MARK IV
Sample was monodisperse. Mixed occupancy of Fabs bound to SARS-CoV-2 spike.
 TFS KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 1.0 2.5 GATAN K3 (6k x 4k) 60.0 1 PHASE FLIPPING AND AMPLITUDE CORRECTION
Final global map in CryoSPARC
 3.0 FSC 0.143 CUT-OFF 152740 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD emd_49835.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 512 512 512 0 0 0 512 512 512 430.08 430.08 430.08 90.0 90.0 90.0 X Y Z -1.3800911 2.014744 -0.00076659396 0.02376077 0.84 0.84 0.84 0.21 AUTHOR Sharpened map emd_49835_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 512 512 512 0 0 0 512 512 512 430.08 430.08 430.08 90.0 90.0 90.0 X Y Z -0.60264134 0.98611677 -0.00034461767 0.07309092 0.84 0.84 0.84 AUTHOR Half map B emd_49835_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 512 512 512 0 0 0 512 512 512 430.08 430.08 430.08 90.0 90.0 90.0 X Y Z -0.6348488 1.0107708 -0.00034647607 0.073109195 0.84 0.84 0.84 AUTHOR Half map A